Renovare Environmental (RENO) 10-Q 15 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 10, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	1,590,383
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		8,337,712

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue
Rental, service and maintenance	$ 358,537	$ 305,862
Equipment sales	232,143	156,865
Total revenue	590,680	462,727
Cost of revenue
Rental, service and maintenance	258,939	243,801
Equipment sales	132,491	104,765
Total Cost of revenue	391,430	348,566
Gross profit	199,250	114,161
Operating expenses
Selling, general and administrative	1,064,629	1,028,649
Research and development	187,501	183,931
Professional fees	649,623	335,845
Depreciation and amortization	29,774	25,774
Total operating expenses	1,931,527	1,574,199
Loss from operations	(1,732,277)	(1,460,038)
Other (expense) income
Interest income	0	355
Interest expense	(296,256)	(149,159)
Total other expense	(296,256)	(148,804)
Net loss	(2,028,533)	(1,608,842)
Other comprehensive income (loss)
Foreign currency translation adjustment	(7,164)	7,906
Comprehensive loss	$ (2,035,697)	$ (1,600,936)
Net loss per share - basic and diluted	$ (0.25)	$ (0.20)
Weighted average number of common shares outstanding - basic and diluted	8,229,712	8,229,712

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets
Cash	$ 320,776	$ 325,987
Accounts and note receivable, net	125,489	140,130
Inventory	439,869	706,017
Prepaid expenses and other current assets	63,724	21,865
Total Current Assets	949,858	1,193,999
Equipment on operating leases, net	1,150,227	1,023,404
Equipment, fixtures and vehicles, net	50,680	54,356
Intangible assets, net	242,542	267,042
Investment in Entsorga West Virginia, LLC	1,034,028	0
MBT facility development costs	36,512	0
Other assets	13,500	13,500
Total Assets	3,477,347	2,552,301
Current Liabilities:
Line of credit	2,463,736	2,463,736
Accounts payable	1,262,708	1,197,277
Accrued interest payable	862,150	411,917
Accrued expenses	596,391	522,727
Warrant liability	105,188	0
Deferred revenue	84,038	61,879
Notes payable	100,000	100,000
Notes payable - related party	275,000	275,000
Unsecured subordinated convertible notes, including related parties of $2,550,000, net of deferred financing costs of $68,846	3,756,154	0
Convertible note, net of deferred financing cost of $8,000 and original issue discounts of $30,058	71,942	0
Advance from related party	463,027	1,213,027
Customer deposits	107,165	36,131
Long-term debt, current portion	7,993	8,525
Total Current Liabilities	10,155,492	6,290,219
Promissory note - related party	4,500,000	2,500,000
Long term accrued interest	48,485	253,000
Unsecured subordinated convertible notes, including related parties of 1,750,000, and $3,800,000, net of deferred financing costs of $25,536 and $118,866 as of March 31, 2017 and December 31, 2016, respectively	1,874,464	4,956,134
Long-term debt, net of current portion	9,473	11,048
Total Liabilities	16,587,914	14,010,401
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued	0	0
Common stock, $0.0001 par value, 20,000,000 shares authorized; 8,229,712 shares issued and outstanding as of March 31, 2017 and December 31, 2016	823	823
Additional paid in capital	9,987,554	9,604,324
Accumulated deficit	(23,100,699)	(21,072,166)
Accumulated other comprehensive gain	1,755	8,919
Total Stockholders' Deficit	(13,110,567)	(11,458,100)
Total Liabilities and Stockholders' Deficit	$ 3,477,347	$ 2,552,301

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	8,229,712	8,229,712
Common stock, shares outstanding	8,229,712	8,229,712
Due to Related Parties, Current	$ 463,027	$ 1,213,027
Unsecured Subordinated Convertible Notes [Member]
Due to Related Parties, Noncurrent	1,750,000	3,800,000
Debt Issuance Costs, Current, Net	68,846
Due to Related Parties, Current	2,550,000
Debt Issuance Costs, Noncurrent, Net	25,536	$ 118,866
Convertible Notes [Member]
Debt Instrument, Unamortized Discount, Current	30,058
Debt Issuance Costs, Current, Net	$ 8,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss:	$ (2,028,533)	$ (1,608,842)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	104,354	92,286
Provision (recovery) - bad debts	22,962	(10,384)
Stock based employee compensation	88,025	138,390
Fees paid in stock	275,148	0
Fees to be paid in warrants	105,187	0
Interest resulting from amortization of financing costs	24,484	0
Changes in operating assets and liabilities	471,960	(187,969)
Changes in operating assets and liabilities:
Net cash used in operations	(936,413)	(1,576,519)
Cash flow from investing activities:
Sale of used machinery and equipment	13,149	0
Investment in Entsorga West Virginia, LLC	(1,034,028)	0
Increase in MBT facility development costs	(36,512)	0
Purchases of equipment, fixtures and vehicles	(1,597)	(1,842)
Net cash (used in) provided by investing activities	(1,058,988)	(1,842)
Cash flows from financing activities:
Net change in line of credit	0	(25,017)
Proceeds from convertible notes with warrants and beneficial conversion feature	100,000	0
Proceeds from series convertible notes	150,000	250,000
Deferred financing costs incurred	(8,000)	(82,730)
Repayments of long-term debt	(2,107)	(2,042)
Net cash provided by financing activities	1,989,893	1,670,211
Effect of exchange rate on cash	297	7,906
Net change in cash	(5,211)	99,756
Cash - beginning of period	325,987	39,195
Cash - end of period	320,776	138,951
Promissory Notes [Member]
Cash flows from financing activities:
Proceeds from convertible notes	786,973	190,000
Repayments of promissory notes	0	(200,000)
Convertible Notes [Member]
Cash flows from financing activities:
Proceeds from convertible notes	500,000	2,250,000
Advances [Member]
Cash flows from financing activities:
Net increases (decreases) of advances	$ 463,027	$ (710,000)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - 3 months ended Mar. 31, 2017 - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2016	$ (11,458,100)	$ 823	$ 9,604,324	$ 8,919	$ (21,072,166)
Balance (in shares) at Dec. 31, 2016		8,229,712
Share-based employee and director compensation	88,025	$ 0	88,025
Share-based professional services compensation	275,148	$ 0	275,148
Share-based professional services compensation (in shares)		0
Warrants issued in connection with Vista debt	16,043	$ 0	16,043	0	0
Beneficial conversion feature of Vista debt	4,014	0	4,014	0	0
Foreign currency translation adjustment	(7,164)			(7,164)
Net loss	(2,028,533)				(2,028,533)
Balance at Mar. 31, 2017	$ (13,110,567)	$ 823	$ 9,987,554	$ 1,755	$ (23,100,699)
Balance (in shares) at Mar. 31, 2017		8,229,712

Basis of Presentation and Going

Basis of Presentation and Going Concern	3 Months Ended
	Mar. 31, 2017
Basis Of Presentation And Going Concern [Abstract]
Basis Of Presentation And Going Concern Disclosure [Text Block]	Nature of Operations Basis of Presentation — The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31, 2016, which contains the audited financial statements and notes thereto, for the years ended December 31, 2016 and 2015 included within the Company’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2017. The financial information as of December 31, 2016 presented hereto is derived from the audited consolidated financial statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2016. The interim results for the three months ended March 31, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for any future interim periods. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern — 2,028,533 1,732,277 936,413 6,745,386 5,924,667 5,181,400 13,110,567 9,205,634 The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management's further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through debt and/or equity raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification. The Company is presently in the process of raising additional non-registered convertible debt and capital for general operations and for investment in several strategic initiatives, as well as commercial debt to support its leasing activities. There is no assurance that the Company will be able to raise sufficient debt or capital to sustain operations or to pursue other strategic initiatives.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2. Summary of Significant Accounting Policies Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. In connection with a professional services agreement, a warrant liability for an agreement to issue warrants that were not issued as of March 31, 2017 has been recognized with a fair value of $ 105,188 2.954 2.75 31.43 2.88 5 For the three months ended March 31, 2017 and 2016, the Company’s effective rate, before valuations, was 39.8 36.7 0.0 The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Accounts and Note Receivable, n

Accounts and Note Receivable, net	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 3. Accounts and Note Receivable, net March 31, December 31, 2017 2016 Accounts receivable $ 214,592 $ 206,219 Note receivable 52,043 52,043 Less: allowance for doubtful accounts and note receivable (141,146) (118,132) $ 125,489 $ 140,130

Inventory

Inventory	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note 4. Inventory Inventory, comprised of finished goods and parts or assemblies, consist of the following: March 31, December 31, 2017 2016 Equipment $ 141,428 $ 191,240 Parts and assemblies 298,441 514,777 $ 439,869 $ 706,017

Equipment on Operating Leases,

Equipment on Operating Leases, net	3 Months Ended
	Mar. 31, 2017
Equipment on Operating leases [Abstract]
Capital Leases in Financial Statements of Lessor Disclosure [Text Block]	Note 5. Equipment on Operating Leases, net Equipment on operating leases consist of the following: March 31, December 31, 2017 2016 Leased equipment $ 2,069,243 $ 1,870,569 Less: accumulated depreciation (919,016) (847,165) $ 1,150,227 $ 1,023,404 During the three months ended March 31, 2017 and 2016, depreciation expense included in cost of revenue, amounted to $ 74,580 59,618 The Company is a lessor of Eco Safe digester units under non-cancellable operating lease agreements expiring through February 2022. During the three months ended March 31, 2017 and 2016, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $ 202,465 149,879 The minimum future estimated contractual payments to be received under these leases as of March 31, 2017 is as follows: Year Ending December 31, 2017 (remaining period) $ 589,605 2018 652,621 2019 542,842 2020 358,782 2021 and thereafter 171,448 Total minimum lease income $ 2,315,298

Equipment, Fixtures and Vehicle

Equipment, Fixtures and Vehicles, net	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 6. Equipment, Fixtures and Vehicles, net Equipment, fixtures and vehicles consist of the following: March 31, December 31, 2017 2016 Computer software and hardware $ 95,141 $ 93,543 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 212,590 210,992 Less: accumulated depreciation and amortization (161,910) (156,636) $ 50,680 $ 54,356 During the three months ended March 31, 2017 and 2016, depreciation expense amounted to $ 5,274 1,275

Investment in Entsorga West Vir

Investment in Entsorga West Virginia LLC ("EWV")	3 Months Ended
	Mar. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments and Joint Ventures Disclosure [Text Block]	Note 7. Investment in Entsorga West Virginia LLC (“EWV”) Effective January 1, 2017, the Company executed several agreements to acquire up to approximately a 40 60,000 1,034,028 17.2 23.1 1,034,028 17.2 (unaudited) December 31, 2016 (a) Current assets - cash $ 4,240 Non-current assets: Restricted cash 20,087,657 Facility under development and construction 8,776,505 Total Assets $ 28,868,402 Current liabilities $ - Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs 23,383,869 Membership equity 5,484,533 $ 28,868,402 (a) The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV and as that period is before the Company’s investment, no operating results have been presented. EWV has financed the development and construction of the facility through $ 25,000,000

MBT Facility Development Costs

MBT Facility Development Costs	3 Months Ended
	Mar. 31, 2017
Facility development [Abstract]
Facility development [Text Block]	Note 8. MBT Facility Development Costs On March 1, 2017 the Town Counsel of New Windsor, NY approved, subject to a 30 day petition period during which certain voters could object, the sale of 12 acres of property to the Company for the development of a Mechanical Biological Treatment (“MBT”) facility. On April 3, 2017, the Town Clerk of New Windsor certified that there had not been any objections raised and the agreement was executed on April 10, 2017. The purchase price of the property is $1,092,000, subject to reduction for option payments made by the Company in the monthly amount of $3,500 for the first 12 months and $6,000 per month for the following 12 months, until the closing. The purchase of the property is contingent upon the Company obtaining: necessary permits to allow construction of a Mechanical Biological Treatment (“MBT”) facility; approvals from state and local authorities; financing for the construction of the MBT facility; contracts for offtake of Solid Recovered Fuel; and the satisfaction of the Company’s due diligence investigation of the property. The contract also contains customary representations warranties and covenants of the parties for like transactions. As of March 31, 2017, the financial statements include costs related to the New Windsor, NY site, including those related to the land option payments, legal costs and survey costs of $ 14,000

Intangibles Assets, net

Intangibles Assets, net	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 9. Intangibles Assets, net Intangible assets consist of the following: Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount March 31, 2017: Distribution agreements 10 2.6 $ 902,000 $ (660,218) $ 241,782 Website 3 0.05 23,388 (22,628) 760 Intangible assets, net $ 925,388 $ (682,846) $ 242,542 December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042 During the three months ended March 31, 2017 and 2016, amortization expense, included in depreciation and amortization of operating expenses, amounted to $ 24,500 24,499 At March 31, 2017, future annual estimated amortization expense is summarized as follows: Year Ending December 31, 2017 (Remaining period) $ 68,409 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 242,542

Risk Concentrations

Risk Concentrations	3 Months Ended
	Mar. 31, 2017
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	Note 10. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. United States International Total 2017: Revenue, for the three months ended March 31, 2017 $ 382,245 $ 208,435 $ 590,680 Non-current tangible assets, as of March 31, 2017 1,142,625 71,782 1,214,407 2016: Revenue, for the three months ended March 31, 2016 $ 411,100 $ 51,627 $ 462,727 Non-current tangible assets, as of December 31, 2016 1,019,664 71,596 1,091,260 Major customers - 10 14 12 10 12 As of March 31, 2017, two customers represented at least 10 11 10 10 22 10 Vendor concentration - 10 30 12 10 72 10 As of March 31, 2017, two vendors represented at least 10% of accounts payable, accounting for 27 1.9 20 10 32 1.9 21

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 11. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a transaction. The table below presents direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. March 31, December 31, 2017 2016 Assets: Intangible assets, net (a) $ 241,782 $ 264,333 Liabilities: Accounts payable 154,147 85,374 Accrued interest payable 747,164 390,812 Long term accrued interest 48,053 187,667 Notes payable 275,000 275,000 Advance from related party (b) 463,027 1,213,027 Promissory note - related parties (c) 4,500,000 2,500,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 2,250,000 Series B - Unsecured subordinated convertible notes (e) 1,750,000 1,250,000 Series V - Unsecured subordinated convertible notes (f) 300,000 300,000 Other: Line of credit guarantee (g) 2,463,736 2,463,736 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Three Months Ended 2017 2016 S, G & A - Rent expense (h) $ 13,246 $ 13,050 Cost of revenues – Rent expense (h) 10,810 10,650 S, G & A - Consulting expense (a) 50,000 50,000 Interest expense 203,346 87,866 Cost of revenue, inventory or equipment on operating leases acquired (a and i) 53,937 202,248 There were no revenues earned from related parties during the three months ended March 31, 2017 and 2016. Prior to the Company’s investment in Entsorga West Virginia, the Company provided environmental and project management services that amounted to $27,055 and $12,000 for the three months ended March 31, 2017 and 2016, respectively. (a.) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. (b.) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (c.) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $1,000,000 (the “Promissory Note”). This note has been amended most recently effective February 1, 2017. The amended note provides for up to $4,500,000 in borrowings, an interest rate of 13% per annum, which is subject to prospective reduction to 10% upon the Company’s completion of raising $7,500,000 in connection with an offering of unsecured subordinated convertible notes and warrants and is due on the earlier of (a) a change of control, (b) an event of non-payment default, (c) the two-year anniversary of the Promissory Note (February 1, 2019), or (d) a Qualified Financing. For purposes of the Promissory Note, a Qualified Financing is defined as the first issuance of debt or equity by the Company through which the Company received gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors. (d.) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (e.) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (f.) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $300,000 in accounts payable by the Company for a $300,000 note. (g.) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. (h.) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Year Ending December 31, 2017 (Remaining period) $ 73,010 2018 98,524 2019 100,003 2020 41,926 Total $ 313,463 (i.) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9% shareholder of BioHiTech.

Debt

Debt	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 12. Debt March 31, 2017 December 31, 2016 Related Related Total Party Total Party Line of credit $ 2,463,736 $ - $ 2,463,736 $ - Unsecured subordinated convertible notes: Series A 3,331,154 2,250,000 3,310,500 2,250,000 Series B 1,874,464 1,750,000 1,220,634 1,250,000 Series V 425,000 300,000 425,000 300,000 Convertible note 71,942 - Promissory note - related party 4,500,000 4,500,000 2,500,000 2,500,000 Notes payable 375,000 275,000 375,000 275,000 Advances 463,027 463,027 1,213,027 1,213,027 Long term debt - other, current and long term portion 17,466 - 19,573 - Series B Unsecured Subordinated Convertible Promissory Notes – 650,000 500,000 Convertible Note – 100,000 110,000 4,014 24,750 16,043 2.954 4.00 31.43 2.88 5 The note allows for fundings representing up to $ 550,000 110,000 9.5 2.85 65 25 The warrant provides for the acquisition of up to 24,750 share of common stock at $ 4.00 Non- Year Ending December 31, Amortizing Amortizing * Total 2017 (Remaining period) $ 6,419 $ 375,000 $ 381,419 2018 5,410 5,725,000 5,730,410 2019 5,199 4,500,000 4,505,199 2020 438 - 438 Total $ 17,466 $ 10,600,000 $ 10,617,466 * Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period based maturity condition. Interest Expense -

Equity Transactions

Equity Transactions	3 Months Ended
	Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 13. Equity Transactions Shareholder Information and Marketing Agreement – 8,000 3,200 8,053 4,800 12,952 Shareholder Awareness Consulting Agreement – 100,000 89,063 267,094 Series A and B Warrants – 120 Maxim Warrants - 10 3.75 5 Barksdale Warrants - 140,000 5.0 Other Warrants - The warrants allow the holders to acquire up to $80,000 of the Company’s common stock at a price of 120% of the closing price of the Company’s first issuance of equity in one, or a series of related transactions, through which the Company receives gross proceeds of $5.0 million or more from one or more financial institutions or accredited investors.

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 14. Equity Incentive Plans During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 371,250 347,500 74,791 2017 2016 Stock options $ 18,094 $ 138,390 Restricted stock units 69,931 - $ 88,025 $ 138,390 Weighted Average Weighted Remaining Total Number of Average Contractual Aggregate Number of Exercisable Exercise Life Intrinsic Options Options Price (in Years) Value Outstanding at December 31, 2016 363,750 90,418 $ 3.75 9.17 - Granted or vested - 79,091 $ 3.75 8.62 - Exercised - - - - - Forfeited or canceled (25,945) - 3.75 - - Outstanding at March 31, 2017 337,805 169,509 $ 3.75 8.62 $ - Number of Shares Unvested balance at December 31, 2016 331,667 Granted - Vested - Forfeited or Canceled (10,555) Unvested balance at March 31, 2017 321,112

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 15. Commitments and Contingencies From time to time, the Company is involved in legal matters arising in the ordinary course of business, including matters that relate to items for which the Company has accrued their contractual obligations, but are disputing payment for. The Company has one such matter relating to a professional services agreement in litigation that it believes does not present a material risk to the Company. While the Company believes that these such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

Operating Leases

Operating Leases	3 Months Ended
	Mar. 31, 2017
Leases, Operating [Abstract]
Operating Leases of Lessor Disclosure [Text Block]	Note 16. Operating Leases The Company rents its headquarters and attached warehousing space from a related party (see Note 11) and their research and development office from an unrelated party under operating leases. The research and development office lease commenced in October 2015 and will expire in 2018 Year Ending December 31, 2017 (Remaining period) 89,863 2018 115,710 2019 100,003 2020 41,926 Total $ 347,502 Total rent expense under all operating leases amounted to $ 32,951 19,451

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	3 Months Ended
	Mar. 31, 2017
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash Flow, Supplemental Disclosures [Text Block]	Note 17. Supplemental Consolidated Statement of Cash Flows Information Three Months Ended March 31, 2017 2016 Cash flows of operating assets and liabilities: Accounts and note receivable $ (8,064) $ 95,435 Inventory 54,648 (146,519) Prepaid expenses and other assets (41,796) 40,062 Accounts payable 65,023 (298,604) Accrued interest payable 245,718 111,272 Accrued expenses 65,027 (85,943) Deferred revenue 20,370 93,029 Customer deposits 71,034 3,299 Net cash flows of operating assets and liabilities $ 471,960 $ (187,969) Supplementary cash flow information: Cash paid during the year for: Interest $ 26,602 $ 24,165 Income taxes - - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 213,672 $ 114,219 Accrued interest added to principle of promissory note - related party - 263,027 Conversion of advances from related party to promissory note 1,213,027 -

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	Note 18. Recent Accounting Pronouncements During the three months ended March 31, 2017, the Company implemented the following recent accounting pronouncements: Stock Compensation - Inventory - Statement of Cash Flows – In August 2016, the FASB issued Accounting Standards Update No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows of cash flows with the objective of reducing the existing diversity in practice related to eight specific cash flow issues. The Company has not yet implemented the following recent accounting pronouncements: Revenue from Contracts with Customers - Leases - Leases).

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 19. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. Authorized Common Shares 0.0001 20,000,000 50,000,000 2017 Executive Stock Incentive Plan 1,000,000 Advance from Related Parties –

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
Revenue Recognition, Policy [Policy Text Block]	Product and Services Revenue Recognition
Revenue Recognition Leases [Policy Text Block]	Lease Revenue Recognition
Fair Value Measurement, Policy [Policy Text Block]	Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. In connection with a professional services agreement, a warrant liability for an agreement to issue warrants that were not issued as of March 31, 2017 has been recognized with a fair value of $ 105,188 2.954 2.75 31.43 2.88 5
Equity Method Investments, Policy [Policy Text Block]	Equity Method Based Investments —
Income Tax, Policy [Policy Text Block]	Income Taxes For the three months ended March 31, 2017 and 2016, the Company’s effective rate, before valuations, was 39.8 36.7 0.0
Earnings Per Share, Policy [Policy Text Block]	Loss per Share The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Accounts and Note Receivable,27

Accounts and Note Receivable, net (Tables)	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	Accounts and note receivable consists of the following: March 31, December 31, 2017 2016 Accounts receivable $ 214,592 $ 206,219 Note receivable 52,043 52,043 Less: allowance for doubtful accounts and note receivable (141,146) (118,132) $ 125,489 $ 140,130

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory, comprised of finished goods and parts or assemblies, consist of the following: March 31, December 31, 2017 2016 Equipment $ 141,428 $ 191,240 Parts and assemblies 298,441 514,777 $ 439,869 $ 706,017

Equipment on Operating Leases29

Equipment on Operating Leases, net (Tables)	3 Months Ended
	Mar. 31, 2017
Equipment on Operating Leases, Net [Abstract]
Schedule of Property Subject to or Available for Operating Lease [Table Text Block]	Equipment on operating leases consist of the following: March 31, December 31, 2017 2016 Leased equipment $ 2,069,243 $ 1,870,569 Less: accumulated depreciation (919,016) (847,165) $ 1,150,227 $ 1,023,404
Schedule Of Future Minimum Rental Payments Receivable For Operating Leases [Table Text Block]	The minimum future estimated contractual payments to be received under these leases as of March 31, 2017 is as follows: Year Ending December 31, 2017 (remaining period) $ 589,605 2018 652,621 2019 542,842 2020 358,782 2021 and thereafter 171,448 Total minimum lease income $ 2,315,298

Equipment, Fixtures and Vehic30

Equipment, Fixtures and Vehicles, net (Tables)	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Equipment, fixtures and vehicles consist of the following: March 31, December 31, 2017 2016 Computer software and hardware $ 95,141 $ 93,543 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 212,590 210,992 Less: accumulated depreciation and amortization (161,910) (156,636) $ 50,680 $ 54,356

Investment in Entsorga West V31

Investment in Entsorga West Virginia LLC ("EWV") (Tables)	3 Months Ended
	Mar. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments [Table Text Block]	Summarized financial information for EWV is as follows: (unaudited) December 31, 2016 (a) Current assets - cash $ 4,240 Non-current assets: Restricted cash 20,087,657 Facility under development and construction 8,776,505 Total Assets $ 28,868,402 Current liabilities $ - Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs 23,383,869 Membership equity 5,484,533 $ 28,868,402 (a) The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV and as that period is before the Company’s investment, no operating results have been presented.

Intangibles Assets, net (Tables

Intangibles Assets, net (Tables)	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	Intangible assets consist of the following: Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount March 31, 2017: Distribution agreements 10 2.6 $ 902,000 $ (660,218) $ 241,782 Website 3 0.05 23,388 (22,628) 760 Intangible assets, net $ 925,388 $ (682,846) $ 242,542 December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	At March 31, 2017, future annual estimated amortization expense is summarized as follows: Year Ending December 31, 2017 (Remaining period) $ 68,409 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 242,542

Risk Concentrations (Tables)

Risk Concentrations (Tables)	3 Months Ended
	Mar. 31, 2017
Risks and Uncertainties [Abstract]
Revenue from External Customers by Geographic Areas [Table Text Block]	Gross revenues and net non-current tangible assets on a domestic and international basis is as follows: United States International Total 2017: Revenue, for the three months ended March 31, 2017 $ 382,245 $ 208,435 $ 590,680 Non-current tangible assets, as of March 31, 2017 1,142,625 71,782 1,214,407 2016: Revenue, for the three months ended March 31, 2016 $ 411,100 $ 51,627 $ 462,727 Non-current tangible assets, as of December 31, 2016 1,019,664 71,596 1,091,260

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2017
Schedule of Related Party Transactions [Table Text Block]	The table below presents direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. March 31, December 31, 2017 2016 Assets: Intangible assets, net (a) $ 241,782 $ 264,333 Liabilities: Accounts payable 154,147 85,374 Accrued interest payable 747,164 390,812 Long term accrued interest 48,053 187,667 Notes payable 275,000 275,000 Advance from related party (b) 463,027 1,213,027 Promissory note - related parties (c) 4,500,000 2,500,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 2,250,000 Series B - Unsecured subordinated convertible notes (e) 1,750,000 1,250,000 Series V - Unsecured subordinated convertible notes (f) 300,000 300,000 Other: Line of credit guarantee (g) 2,463,736 2,463,736 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Three Months Ended 2017 2016 S, G & A - Rent expense (h) $ 13,246 $ 13,050 Cost of revenues – Rent expense (h) 10,810 10,650 S, G & A - Consulting expense (a) 50,000 50,000 Interest expense 203,346 87,866 Cost of revenue, inventory or equipment on operating leases acquired (a and i) 53,937 202,248 There were no revenues earned from related parties during the three months ended March 31, 2017 and 2016. Prior to the Company’s investment in Entsorga West Virginia, the Company provided environmental and project management services that amounted to $27,055 and $12,000 for the three months ended March 31, 2017 and 2016, respectively. (a.) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. (b.) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (c.) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $1,000,000 (the “Promissory Note”). This note has been amended most recently effective February 1, 2017. The amended note provides for up to $4,500,000 in borrowings, an interest rate of 13% per annum, which is subject to prospective reduction to 10% upon the Company’s completion of raising $7,500,000 in connection with an offering of unsecured subordinated convertible notes and warrants and is due on the earlier of (a) a change of control, (b) an event of non-payment default, (c) the two-year anniversary of the Promissory Note (February 1, 2019), or (d) a Qualified Financing. For purposes of the Promissory Note, a Qualified Financing is defined as the first issuance of debt or equity by the Company through which the Company received gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors. (d.) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (e.) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering. (f.) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $300,000 in accounts payable by the Company for a $300,000 note. (g.) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. (h.) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of March 31, 2017 under these operating leases are: (i.) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9% shareholder of BioHiTech.
Facility Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum lease payments as of March 31, 2017 under these operating leases are: Year Ending December 31, 2017 (Remaining period) $ 73,010 2018 98,524 2019 100,003 2020 41,926 Total $ 313,463

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Debt Instruments [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Notes, lines, advances and long term debts are comprised of the following: March 31, 2017 December 31, 2016 Related Related Total Party Total Party Line of credit $ 2,463,736 $ - $ 2,463,736 $ - Unsecured subordinated convertible notes: Series A 3,331,154 2,250,000 3,310,500 2,250,000 Series B 1,874,464 1,750,000 1,220,634 1,250,000 Series V 425,000 300,000 425,000 300,000 Convertible note 71,942 - Promissory note - related party 4,500,000 4,500,000 2,500,000 2,500,000 Notes payable 375,000 275,000 375,000 275,000 Advances 463,027 463,027 1,213,027 1,213,027 Long term debt - other, current and long term portion 17,466 - 19,573 -
Schedule of Maturities of Long-term Debt [Table Text Block]	Maturities of Non-Current Promissory Note, Long Term Debt and Unsecured Subordinated Convertible Notes – Non- Year Ending December 31, Amortizing Amortizing * Total 2017 (Remaining period) $ 6,419 $ 375,000 $ 381,419 2018 5,410 5,725,000 5,730,410 2019 5,199 4,500,000 4,505,199 2020 438 - 438 Total $ 17,466 $ 10,600,000 $ 10,617,466 * Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period based maturity condition.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	Compensation expense related to the options and restricted stock units during the three months ended March 31, 2017 and 2016 were: 2017 2016 Stock options $ 18,094 $ 138,390 Restricted stock units 69,931 - $ 88,025 $ 138,390
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for the three months ended March 31, 2017: Weighted Average Weighted Remaining Total Number of Average Contractual Aggregate Number of Exercisable Exercise Life Intrinsic Options Options Price (in Years) Value Outstanding at December 31, 2016 363,750 90,418 $ 3.75 9.17 - Granted or vested - 79,091 $ 3.75 8.62 - Exercised - - - - - Forfeited or canceled (25,945) - 3.75 - - Outstanding at March 31, 2017 337,805 169,509 $ 3.75 8.62 $ -
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	The following table summarizes the Company’s restricted stock unit activity for the three months ended March 31, 2017: Number of Shares Unvested balance at December 31, 2016 331,667 Granted - Vested - Forfeited or Canceled (10,555) Unvested balance at March 31, 2017 321,112

Operating Leases (Tables)

Operating Leases (Tables)	3 Months Ended
	Mar. 31, 2017
Research And Development Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The research and development office lease commenced in October 2015 and will expire in 2018 Year Ending December 31, 2017 (Remaining period) 89,863 2018 115,710 2019 100,003 2020 41,926 Total $ 347,502

Supplemental Consolidated Sta38

Supplemental Consolidated Statement of Cash Flows Information (Tables)	3 Months Ended
	Mar. 31, 2017
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	Cash flows of non-cash operating assets and liabilities, as well as other supplemental disclosures, are as follows: Three Months Ended March 31, 2017 2016 Cash flows of operating assets and liabilities: Accounts and note receivable $ (8,064) $ 95,435 Inventory 54,648 (146,519) Prepaid expenses and other assets (41,796) 40,062 Accounts payable 65,023 (298,604) Accrued interest payable 245,718 111,272 Accrued expenses 65,027 (85,943) Deferred revenue 20,370 93,029 Customer deposits 71,034 3,299 Net cash flows of operating assets and liabilities $ 471,960 $ (187,969) Supplementary cash flow information: Cash paid during the year for: Interest $ 26,602 $ 24,165 Income taxes - - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 213,672 $ 114,219 Accrued interest added to principle of promissory note - related party - 263,027 Conversion of advances from related party to promissory note 1,213,027 -

Basis of Presentation and Goi39

Basis of Presentation and Going Concern (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss) Attributable to Parent	$ (2,028,533)	$ (1,608,842)	$ 6,745,386
Operating Income (Loss), Total	(1,732,277)	(1,460,038)	5,924,667
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	(936,413)	$ (1,576,519)	5,181,400
Working Capital Deficit	9,205,634
Stockholders' Equity Attributable to Parent	$ (13,110,567)		$ (11,458,100)

Summary of Significant Accoun40

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Summary Of Significant Accounting Policies [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	39.80%	36.70%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	0.00%
Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Warrants Not Settleable in Cash, Fair Value Disclosure	$ 105,188
Share Price	$ 2.954
Fair Value Assumptions, Exercise Price	$ 2.75
Fair Value Assumptions, Expected Volatility Rate	31.43%
Fair Value Assumptions, Risk Free Interest Rate	2.88%
Fair Value Assumptions, Expected Term	5 years

Accounts and Note Receivable,41

Accounts and Note Receivable, net (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Accounts receivable	$ 214,592	$ 206,219
Note receivable	52,043	52,043
Less: allowance for doubtful accounts and note receivable	(141,146)	(118,132)
Accounts Receivable, Net, Current, Total	$ 125,489	$ 140,130

Inventory (Details)

Inventory (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Inventory [Line Items]
Inventory, Net, Total	$ 439,869	$ 706,017
Equipment [Member]
Inventory [Line Items]
Inventory, Net, Total	141,428	191,240
Parts and Assemblies [Member]
Inventory [Line Items]
Inventory, Net, Total	$ 298,441	$ 514,777

Equipment on Operating Leases43

Equipment on Operating Leases, net (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Leased equipment	$ 2,069,243	$ 1,870,569
Less: accumulated depreciation	(919,016)	(847,165)
Property Subject to or Available for Operating Lease, Net, Total	$ 1,150,227	$ 1,023,404

Equipment on Operating Leases44

Equipment on Operating Leases, net (Details 1)	Mar. 31, 2017USD ($)
2017 (remaining period)	$ 589,605
2,018	652,621
2,019	542,842
2,020	358,782
2021 and thereafter	171,448
Total minimum lease income	$ 2,315,298

Equipment on Operating Leases45

Equipment on Operating Leases, net (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Depreciation	$ 74,580	$ 59,618
Operating Leases, Income Statement, Lease Revenue, Total	358,537	305,862
Eco Safe digester [Member]
Operating Leases, Income Statement, Lease Revenue, Total	$ 202,465	$ 149,879

Equipment, Fixtures and Vehic46

Equipment, Fixtures and Vehicles, net (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 212,590	$ 210,992
Less: accumulated depreciation and amortization	(161,910)	(156,636)
Property, Plant and Equipment, Net, Total	50,680	54,356
Computer software and hardware [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	95,141	93,543
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 69,253	$ 69,253

Equipment, Fixtures and Vehic47

Equipment, Fixtures and Vehicles, net (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 29,774	$ 25,774
Equipment Fixtures And Vechicles [Member]
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 5,274	$ 1,275

Investment in Entsorga West V48

Investment in Entsorga West Virginia LLC (“EWV”) (Details)	Dec. 31, 2016USD ($)	[1]
Current assets - cash	$ 4,240
Non-current assets:
Restricted cash	20,087,657
Facility under development and construction	8,776,505
Total Assets	28,868,402
Current liabilities	0
Non-current liabilities - Tax-exempt bonds, net of $1,616,131 of issuance costs	23,383,869
Membership equity	5,484,533
Equity Method Investment, Summarized Financial Information, Liabilities and Equity	$ 28,868,402
[1]	The Company utilizes a three-month lag in reporting its share of equity income or loss in EWV and as that period is before the Company’s investment, no operating results have been presented.

Investment in Entsorga West V49

Investment in Entsorga West Virginia LLC (“EWV”) (Details Textual) - USD ($)	Mar. 31, 2017	Mar. 21, 2017	Jan. 02, 2017	Dec. 31, 2016
Equity Method Investments	$ 1,034,028			$ 0
Unamortized Debt Issuance Expense				$ 1,616,131
Entsorga West Virginia LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired		17.20%	17.20%
Business Acquisiton Purchase Price For one Percentage Interest			$ 60,000
Equity Method Investments		$ 1,034,028	$ 1,034,028
Business Acquisiton, Remaining Voting Interest To Be Acquired At Company Option			23.10%
Maximum [Member] | Entsorga West Virginia LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired			40.00%
Entsorga westvergina,LLC [Member]
Issuance of solid wasted is posal revenue bond	$ 25,000,000

MBT Facility Development Costs

MBT Facility Development Costs (Details Textual) - USD ($)	Apr. 03, 2017	Mar. 31, 2017	Dec. 31, 2016
Land and Land Improvements		$ 36,512	$ 0
Land Option [Member]
Land and Land Improvements		14,000
Legal Cost [Member]
Land and Land Improvements		9,112
Survey Cost [Member]
Land and Land Improvements		$ 13,400
Land [Member] | Subsequent Event [Member]
Payments to Acquire Property, Plant, and Equipment	$ 1,092,000
Monthly Payments For First Twelve Month	3,500
Monthly Payments For Next Twelve Month	$ 6,000

Intangibles Assets, net (Detail

Intangibles Assets, net (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 925,388	$ 925,388
Finite-Lived Intangible Assets, Accumulated Amortization	(682,846)	(658,346)
Finite-Lived Intangible Assets, Net, Total	$ 242,542	$ 267,042
Distribution Rights [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years	10 years
Finite-Lived Intangible Assets, Remaining Amortization Period	2 years 7 months 6 days	2 years 9 months 18 days
Finite-Lived Intangible Assets, Gross	$ 902,000	$ 902,000
Finite-Lived Intangible Assets, Accumulated Amortization	(660,218)	(637,667)
Finite-Lived Intangible Assets, Net, Total	$ 241,782	$ 264,333
Website [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years	3 years
Finite-Lived Intangible Assets, Remaining Amortization Period	18 days	3 months 18 days
Finite-Lived Intangible Assets, Gross	$ 23,388	$ 23,388
Finite-Lived Intangible Assets, Accumulated Amortization	(22,628)	(20,679)
Finite-Lived Intangible Assets, Net, Total	$ 760	$ 2,709

Intangibles Assets, net (Deta52

Intangibles Assets, net (Details 1) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
2,017	$ 68,409
2,018	90,200
2,019	43,533
2,020	20,200
2,021	20,200
Total	$ 242,542	$ 267,042

Intangibles Assets, net (Deta53

Intangibles Assets, net (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 24,500	$ 24,499

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Concentration Risk [Line Items]
Revenue	$ 590,680	$ 462,727
Non-current tangible assets	1,214,407		$ 1,091,260
UNITED STATES
Concentration Risk [Line Items]
Revenue	382,245	411,100
Non-current tangible assets	1,142,625		1,019,664
International [Member]
Concentration Risk [Line Items]
Revenue	208,435	$ 51,627
Non-current tangible assets	$ 71,782		$ 71,596

Risk Concentrations (Details Te

Risk Concentrations (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Vendor One [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	1.90%		1.90%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	14.00%	12.00%
Sales Revenue, Net [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12.00%
Sales Revenue, Net [Member] | Major Customer [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.00%	10.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	11.00%		22.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%
Accounts Receivable [Member] | Major Customer [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%		10.00%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	27.00%		32.00%
Accounts Payable [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	20.00%		21.00%
Accounts Payable [Member] | Vendor Two [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%
Cost Of Revenue [Member] | BioHitech International [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		72.00%
Cost Of Revenue [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	30.00%
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12.00%
Cost Of Revenue [Member] | Vendor [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Assets:
Intangible assets, net		$ 242,542		$ 267,042
Liabilities:
Accounts payable		1,262,708		1,197,277
Accrued interest payable		862,150		411,917
Long term accrued interest		48,485		253,000
Notes payable		100,000		100,000
Advance from related party		463,027		1,213,027
Promissory note - related parties		275,000		275,000
Other:
S, G & A - Rent expense	[1]	13,246	$ 13,050
Cost of revenues - Rent expense	[1]	10,810	10,650
S, G & A - Consulting expense	[2]	50,000	50,000
Interest expense		203,346	87,866
Cost of revenue, inventory or equipment on operating leases acquired	[2],[3]	53,937	$ 202,248
Series A Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[4]	2,250,000		2,250,000
Series B Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[5]	1,750,000		1,250,000
Series V Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[6]	300,000		300,000
Related Party [Member]
Assets:
Intangible assets, net	[2]	241,782		264,333
Liabilities:
Accounts payable		154,147		85,374
Accrued interest payable		747,164		390,812
Long term accrued interest		48,053		187,667
Notes payable		275,000		275,000
Advance from related party	[7]	463,027		1,213,027
Promissory note - related parties	[8]	4,500,000		2,500,000
Other:
Line of credit guarantee	[9]	$ 2,463,736		$ 2,463,736
[1]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.
[2]	Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties.
[3]	Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9% shareholder of BioHiTech.
[4]	Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering.
[5]	Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, certain related parties participated in such offering.
[6]	Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, BioHiTech International, see note a, above, exchanged $300,000 in accounts payable by the Company for a $300,000 note.
[7]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.
[8]	Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $1,000,000 (the “Promissory Note”). This note has been amended most recently effective February 1, 2017. The amended note provides for up to $4,500,000 in borrowings, an interest rate of 13% per annum, which is subject to prospective reduction to 10% upon the Company’s completion of raising $7,500,000 in connection with an offering of unsecured subordinated convertible notes and warrants and is due on the earlier of (a) a change of control, (b) an event of non-payment default, (c) the two-year anniversary of the Promissory Note (February 1, 2019), or (d) a Qualified Financing. For purposes of the Promissory Note, a Qualified Financing is defined as the first issuance of debt or equity by the Company through which the Company received gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors.
[9]	Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line.

Related Party Transactions (D57

Related Party Transactions (Details 1) - Facility Lease [Member]	Mar. 31, 2017USD ($)
2017 (Remaining period)	$ 73,010
2,018	98,524
2,019	100,003
2,020	41,926
Total	$ 313,463

Related Party Transactions (D58

Related Party Transactions (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Jun. 25, 2014
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	5.00%
Unsecured Subordinated Convertible Notes And Warrants Offering	$ 7,500,000
Entsorga West Virginia [Member] | Environmental and Project Management Services [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties	27,055	$ 12,000
BioHiTech [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent			1.90%
Series V Convertible Notes [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	425,000		$ 425,000
Series V Convertible Notes [Member] | BioHiTech [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	300,000
Amended [Member]
Related Party Transaction [Line Items]
Secured Debt	$ 4,500,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Secured Debt [Member]
Related Party Transaction [Line Items]
Secured Debt				$ 1,000,000
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Proceeds from Issuance of Debt	$ 5,000,000

Debt (Details)

Debt (Details) - USD ($)		Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Line of credit		$ 2,463,736	$ 2,463,736
Convertible notes		71,942
Promissory note - related party		4,500,000	2,500,000
Notes payable		375,000	375,000
Advances		463,027	1,213,027
Long term debt - other, current and long term portion		17,466	19,573
Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		3,331,154	3,310,500
Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		1,874,464	1,220,634
Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		425,000	425,000
Related Party [Member]
Debt Instrument [Line Items]
Line of credit		0	0
Convertible notes		0
Promissory note - related party		4,500,000	2,500,000
Notes payable		275,000	275,000
Advances	[1]	463,027	1,213,027
Long term debt - other, current and long term portion		0	0
Related Party [Member] | Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		2,250,000	2,250,000
Related Party [Member] | Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		1,750,000	1,250,000
Related Party [Member] | Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Unsecured subordinated convertible notes		$ 300,000	$ 300,000
[1]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.

Debt (Details 1)

Debt (Details 1) - USD ($)		Mar. 31, 2017	Dec. 31, 2016
2017 (Remaining period)		$ 381,419
2,018		5,730,410
2,019		4,505,199
2,020		438
Total		17,466	$ 19,573
Total		10,617,466
Amortizing [Member]
2017 (Remaining period)		6,419
2,018		5,410
2,019		5,199
2,020		438
Total		17,466
Non-Amortizing [Member]
2017 (Remaining period)	[1]	375,000
2,018	[1]	5,725,000
2,019	[1]	4,500,000
2,020	[1]	0
Total	[1]	$ 10,600,000
[1]	Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period based maturity condition.

Debt (Details Textual)

Debt (Details Textual)	3 Months Ended
	Mar. 31, 2017USD ($)$ / sharesshares
Debt Instrument, Interest Rate, Effective Percentage	5.00%
Convertible Debt	$ 71,942
Convertible Debt [Member]
Debt Instrument, Face Amount	$ 110,000
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 2.85
Debt Instrument, Interest Rate, Effective Percentage	9.50%
Proceeds from Notes Payable	$ 100,000
Share Price | $ / shares	$ 4
Fair Value Assumptions, Expected Term	5 years
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	65.00%
Debt Instrument, Convertible, Threshold Consecutive Trading Days	25 years
Debt Instrument, Convertible, Beneficial Conversion Feature	$ 4,014
Convertible Debt	110,000
Convertible Debt [Member] | Convetible Debt Warrants [Member]
Warrants and Rights Outstanding	$ 16,043
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	24,750
Share Price | $ / shares	$ 2.954
Fair Value Assumptions, Exercise Price | $ / shares	$ 4
Fair Value Assumptions, Expected Volatility Rate	31.43%
Fair Value Assumptions, Risk Free Interest Rate	2.88%
Fair Value Assumptions, Expected Term	5 years
Convertible Debt [Member] | Minimum [Member]
Debt Instrument, Face Amount	$ 550,000
Series B Convertible Notes [Member]
Proceeds from Notes Payable	650,000
Series B Convertible Notes [Member] | Officer or Shareholders [Member]
Proceeds from Notes Payable	$ 500,000

Equity Transactions (Details Te

Equity Transactions (Details Textual) - USD ($)	Feb. 10, 2016	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Description Of Other Warrants		The warrants allow the holders to acquire up to $80,000 of the Companys common stock at a price of 120% of the closing price of the Companys first issuance of equity in one, or a series of related transactions, through which the Company receives gross proceeds of $5.0 million or more from one or more financial institutions or accredited investors.
Shareholder Information and Marketing Agreement [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		3,200	4,800
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			8,000
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 8,053	$ 12,952
Shareholder Awareness Consulting Agreement [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		89,063
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 267,094
Series A and B Warrants [Member]
Conversion Price of Notes,Percentage		120.00%
Maxim Warrants [Member]
Percentage Of Warrants Exercisable Of Common Shares	10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.75
Warrant Expiration Terms	5 years
Barksdale Warrants [Member]
Proceeds from Issuance of Warrants				$ 5,000,000
Warrants To Purchase Of Common Stock				$ 140,000

Equity Incentive Plans (Details

Equity Incentive Plans (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Stock options	$ 18,094	$ 138,390
Restricted stock units	69,931	0
Share-based compensation	$ 88,025	$ 138,390

Equity Incentive Plans (Detai64

Equity Incentive Plans (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Number of Options, Beginning Balance	363,750
Number of Options, Granted or vested	0
Number of Options, Exercised	0
Number of Options, Forfeited or Canceled	(25,945)
Number of Options, Ending Balance	337,805	363,750
Number of Options, Exercisable, Beginning Balance	90,418
Number of Options, Exercisable, Granted or vested	79,091
Number of Options, Exercisable, Exercised	0
Number of Options, Exercisable, Forfeited or canceled	0
Number of Options, Exercisable, Ending Balance	169,509	90,418
Weighted Average Exercise Price, Beginning Balance	$ 3.75
Weighted Average Exercise Price, Granted or vested	3.75
Weighted Average Exercise Price, Exercised	0
Weighted Average Exercise Price, Forfeited or Canceled	3.75
Weighted Average Exercise Price, Ending Balance	$ 3.75	$ 3.75
Weighted Average Remaining Contractual Life (in Years), Granted or vested	8 years 7 months 13 days
Weighted Average Remaining Contractual Life (in Years), Outstanding	8 years 7 months 13 days	9 years 2 months 1 day
Aggregate Intrinsic Value, Outstanding	$ 0	$ 0

Equity Incentive Plans (Detai65

Equity Incentive Plans (Details 2)	3 Months Ended
	Mar. 31, 2017shares
Unvested balance at December 31, 2016	331,667
Granted	0
Vested	0
Forfeited or Canceled	(10,555)
Unvested balance at March 31, 2017	321,112

Equity Incentive Plans (Detai66

Equity Incentive Plans (Details Textual) - shares	1 Months Ended	3 Months Ended	12 Months Ended
	Apr. 15, 2016	Mar. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		0
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	347,500
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			371,250
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		750,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		74,791

Operating Leases (Details)

Operating Leases (Details) - Research And Development Lease [Member]	Mar. 31, 2017USD ($)
Operating Leased Assets [Line Items]
2017 (Remaining period)	$ 89,863
2,018	115,710
2,019	100,003
2,020	41,926
Total	$ 347,502

Operating Leases (Details Textu

Operating Leases (Details Textual) - USD ($)		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense	[1]	$ 13,246	$ 13,050
Research And Development Lease [Member]
Operating Leased Assets [Line Items]
Lessor Leasing Arrangements, Operating Leases, Renewal Term		1 year
Operating Lease Commencement Year		2,015
Operating Lease Expiration Term		2,018
Operating Leases, Rent Expense		$ 32,951	$ 19,451
[1]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.

Supplemental Consolidated Sta69

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows of operating assets and liabilities:
Accounts and note receivable	$ (8,064)	$ 95,435
Inventory	54,648	(146,519)
Prepaid expenses and other assets	(41,796)	40,062
Accounts payable	65,023	(298,604)
Accrued interest payable	245,718	111,272
Accrued expenses	65,027	(85,943)
Deferred revenue	20,370	93,029
Customer deposits	71,034	3,299
Net cash flows of operating assets and liabilities	471,960	(187,969)
Supplementary cash flow information:
Cash paid during the year for: Interest	26,602	24,165
Cash paid during the year for: Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	213,672	114,219
Accrued interest added to principle of promissory note - related party	0	263,027
Conversion of advances from related party to promissory note	$ 1,213,027	$ 0

Subsequent Events (Details Text

Subsequent Events (Details Textual) - USD ($)	Apr. 30, 2017	Mar. 31, 2017	Jan. 25, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Common Stock, Shares Authorized		20,000,000	50,000,000	20,000,000
Common Stock, par value (in dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Due to Related Parties, Current		$ 463,027		$ 1,213,027
Executive Equity Incentive 2017 Plan [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			1,000,000
Subsequent Event [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	13.00%
Due to Related Parties, Current	$ 325,000